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ABSTRACT
Background: The correlation between inflammatory cells and airway smooth muscle plays fundamental roles
in the pathophysiology of asthma. This study was designed to determine whether pre-exposure of airway
smooth muscle to sphingosine-1-phosphate (S1P), which is released from mast cells by allergic reactions,
causes a deterioration of β-adrenoceptor function.
Methods: Isometric tension and the ratio of fluorescence intensities at 340 and 380 nm (F340F380), an indica-
tor of intracellular Ca2+ levels, were simultaneously measured using fura-2 loaded guinea-pig tracheal tissues.
Intracellular cAMP levels were also measured.
Results: Pre-exposure to S1P caused a reduction in the inhibitory effects of 0.3 μM isoprenaline, a β-
adrenoceptor agonist, and 10 μM forskolin, a direct activator of adenylyl cyclase, against 1 μM methacholine-
induced contraction in concentration- and time- dependent manners. In contrast, the values of F340F380 were
not augmented under this experimental condition. After incubation with S1P in the presence of 0.001-1 μM Y-
27632, a Rho-kinase inhibitor, the reduced responsiveness to forskolin induced by S1P was reversed in a
concentration-dependent manner. Moreover, pre-treatment with pertussis toxin (PTX), an inhibitor of Gi, sup-
pressed the loss of forskolin-induced relaxation induced by S1P. Pre-exposure to S1P markedly inhibited the
augmentation of cAMP accumulation induced by forskolin. However, addition of Y-27632 and pre-exposure to
PTX returned forsokin-induced cAMP accumulation to the control level.
Conclusions: Pre-exposure to S1P causes heterologus desensitization of β-adrenoceptors by increasing the
sensitivity of airway smooth muscle to intracellular Ca2+. Ca2+ sensitization regulated by Gi and Rho-kinase is
involved in this phenomenon.
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INTRODUCTION
Sphingosine-1-phosphate (S1P), a bioactive sphingol-
ipid metabolite, is released from inflammatory cells
such as mast cells that are implicated in the patho-
physiology of asthma. In vitro, FcεRI cross-linking,
which elicits the IgE-mediated allergic reaction, acti-
vates sphingosine kinase, resulting in the conversion
of sphingosine to S1P. Extracellular S1P not only ef-
fects eosinophil infiltration of the airway wall1 but
also affects smooth muscle by augmenting the pro-
duction of inflammatory cytokines, contraction, and
the response to contractile agonists.2-4 Moreover, S1P
disrupts the epithelial cell barrier integrity (tight
junctions) in the respiratory system.5 Previous clini-
cal trials have demonstrated that the level of S1P is
markedly elevated in bronchoalveolar lavage (BAL)
fluid from patients with asthma after allergen chal-
lenges.3,6 Therefore, external S1P may be involved in
the pathophysiology of asthma by acting as a lipid
mediator.
The physiological response induced by S1P was
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shown to be mediated by binding to a family of spe-
cific GTP-binding (G)-protein coupled receptors
(S1P1-5) that are linked to downstream signal trans-
duction pathways.7,8 It is generally considered that
S1P2, which is coupled to the inhibitory trimeric G-
protein of adenylyl cyclase, Gi, may play an important
physiological role in the respiratory system.2 In
smooth muscle including airways and other tissues,
S1P causes contraction and increases the concentra-
tion of intracellular Ca2+ ([Ca2+]i). These effects are
mediated by pertussis toxin-sensitive processes.9-11
This S1P-induced Ca2+ dynamics is due to voltage-
dependent Ca2+ channels2 or nonselective Ca2+ in-
flux4 in airway smooth muscle.
RhoA, a monomeric G protein, and Rho-kinase, an
effector molecule of RhoA, are involved in the down-
stream signal transduction pathways of S1P2Gi.12
The RhoARho-kinase processes cause the contrac-
tion, proliferation and migration of airway smooth
muscle cells and inflammatory cells by increasing cel-
lular sensitivity to intracellular Ca2+.13-16 These proc-
esses may be closely involved in most of the basic
pathophysiological features of asthma, such as airflow
limitation, eosinophil recruitment, airway hyperre-
sponsiveness and airway remodeling.15,16
Pre-exposure to S1P enhances methacholine
(MCh)-induced contraction of isolated airway smooth
muscle by Ca2+ sensitization via inactivation of RhoA-
mediated myosin phosphatase (myosin phosphatase
target subunit 1, MYPT1).4 Moreover, in vivo aug-
mented responsiveness to MCh following allergen
challenges is suppressed by a sphingosine kinase in-
hibitor.17,18 These results indicate that the stimula-
tory linkage between S1P and RhoA plays a key role
in airway hyperresponsiveness. However, little is cur-
rently known about involvement of this linkage in the
pathophysiology of asthma.
This study was designed to determine whether pre-
exposure of airway smooth muscle to S1P leads to a
deterioration of β-adrenoceptor function. Moreover,
we examined the relationship between Ca2+ signaling
and post-receptor pathways that are known intracellu-
lar mechanisms underlying β-adrenergic desensitiza-
tion by S1P, with a focus on S1PGiRhoA processes.
METHODS
TISSUE PREPARATION AND TENSION RE-
CORDS
The methods were essentially similar to those de-
scribed previously.19 The tracheas were excised from
male Hartley guinea-pigs (300 - 350 g) after injection
of pentobarbital (150 mgkg intraperitoneally [i.p.]).
The tracheal rings were opened by cutting them lon-
gitudinally in the cartilaginous region, and the epithe-
lium was dissected away. The muscle strips contain-
ing one cartilage ring were removed and were placed
vertically in an organ bath to measure tension isomet-
rically. The passive tension was adjusted to 0.5 g after
equilibration of the preparation in the normal bathing
solution for 60 min. After the control response to 1
μM methacholine (MCh) was established, the experi-
ments were started. The normal bathing solution was
composed of 137 mM NaCl, 5.9 mM KHCO3, 1.2 mM
CaCl2, 1.2 mM MgCl2 and 11.8 mM glucose, and was
bubbled with a gas mixture of 99% O2 - 1% CO2 (pH
7.4). The bathing solution was perfused at a constant
flow of 3 mlmin. Indomethacin (2 μM) was perfused
throughout the isometric tension recording to abolish
the spontaneous mechanical tone. The temperature
of the organ bath was maintained at 37℃. All animal
procedures were approved by the Animal Care and
Use Committee of Nagoya University Graduate
School of Medicine.
THE SIMULTANEOUS MEASUREMENT OF ISO-
METRIC TENSION AND FURA-2 FLUORES-
CENCE
The methods have been described in detail previ-
ously.20 Briefly, muscle strips were treated with 10
μM of fura-2acetoxymethyl (fura-2AM) for 4 h at
room temperature (22 - 24℃). The non-cytotoxic de-
tergent, pluronic F-127 (0.01% wtvol), was added to
increase the solubility of fura-2AM. After the load-
ing, the chamber was filled with the normal solution.
Isometric tension and the fura-2 fluorescence of mus-
cle strips were measured simultaneously, using a dis-
placement transducer and a spectrofluorometer
(CAF-110, Japan Spectroscopic, Tokyo, Japan). The
intensity of fura-2 fluorescence due to excitation at
340 (F340) and 380 (F380) nm was measured after
background subtraction. The absolute amount of in-
tracellular Ca2+ concentration ([Ca2+]i) was not calcu-
lated because the dissociation constant of fura-2 for
Ca2+ in smooth muscle cytoplasm is known to be dif-
ferent from that obtained in vitro.21 The ratio of F340
to F380 (F340F380) was used as a relative indicator of
[Ca2+]i. After equilibration of the response to MCh,
the experiments were started. Muscle tension and
F340F380 in response to the normal bathing were
taken as 0%, and the values of percent contraction and
F340F380 at each experimental condition were ex-
pressed by taking the values induced by 1 μM of
MCh under each experimental condition as 100%. In-
domethacin was also perfused throughout the experi-
ments to abolish the spontaneous tone.
EXPERIMENTAL PROTOCOL OF TENSION RE-
CORDS
To determine the effect of pre-treatment of S1P on β-
adrenergic action, the inhibitory action of iso-
preneline (ISO), a β-adrenoceptor agonist, on MCh-
induced contraction was examined before and after
exposure to S1P. S1P (<1 μM) was applied because
pre-exposure to S1P did not cause augmentation of
MCh-induced contraction.4 MCh (1 μM) was applied
to the tissues in the presence of 0.3 μM ISO for 10
Effects of S1P on β-adrenergic Action
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min, and the tissue was then washed by perfusion
with normal bathing solution for 15 min. Next, the tis-
sues were exposed to S1P (0.001 - 0.1 μM) for 15 - 60
min. After washing out S1P by perfusing the normal
bathing solution for 15 min, MCh with ISO was also
applied to the identical tissues in the same way. To
determine the effect of pre-treatment with S1P on the
inhibitory action of cAMP-related agents that bypass
β-adrenoceptors, the inhibitory effects of forskolin, a
direct activator of adenylyl cyclase, on MCh-induced
contraction were examined before and after exposure
to S1P in the same way. To examine the involvement
of Ca2+ signaling in the effects of S1P, MCh was ap-
plied in the presence of ISO before and after expo-
sure to S1P in the same way using the fura-2 loaded
tissues. In the fura-2 experiments, because the ex-
periments must be carried out under the condition
that the loaded fluorescence is steady, the periods for
application and washing described earlier were short-
ened as described in a previous report.22 To deter-
mine the involvement of Ca2+ sensitization mediated
by RhoA, the tissues were exposed to S1P in the pres-
ence of Y-27632, a selective inhibitor of Rho-kinase.
To determine the involvement of Ca2+ dynamics me-
diated by Ca2+ influx, the tissues were exposed to S1P
in the presence of SKF-96365, a nonselective inhibitor
of Ca2+ channels. To determine the involvement of Gi,
the inhibitory G protein of adenylyl cyclase, the strips
were pre treated with 1 μgml PTX for -6 h. Time-
matched control tissues were treated similarly to the
test tissues, but were exposed continuously to the
normal bathing solution (sham incubation) instead of
to S1P and PTX.
cAMP MEASUREMENT
Measurement of cAMP was performed as previously
described.23-26 Muscle strips of guinea-pig trachea (-2
× 2 × 10 mm) were prepared by dissecting parallel to
the longitudinal axis of the muscle. The strips were
equilibrated in the normal bathing solution at 37℃
for 60 min, and the experiments were then started.
All experiments were conducted in the presence of 2
μM indomethacin. At the end of each incubation pe-
riod, the strips were rapidly removed, blotted dry, fro-
zen with liquid nitrogen and stored at -80℃. Frozen
strips were homogenized in cold 6% trichloroacetic
acid at 2-8℃ and the homogenate was centrifuged at
2000 g for 15 min at 4℃. Precipitated protein was
separated and used for the measurement of protein
content using bovine serum albumin as a standard.
The supernatant was washed four times with 5 vol-
umes of water-saturated diethyl ether and the aque-
ous extract remaining was lyophilized for assay of
cAMP content. The concentrations of cAMP were es-
timated using a commercially available enzyme-
immunoassay kit (RPN 225; Amersham Life Sciences,
Buckinghamshire, UK) without acetylation. cAMP
content was expressed as picomoles of cAMP per mil-
ligram of protein.
MATERIALS
MCh, ISO, PTX, forskolin, SKF-96365, pluoronic
F127 and indomethacin were obtained from Sigma
Chemical (St. Louis, MO, USA). Y-27632 was ob-
tained from Wako (Osaka, Japan). S1P was obtained
from BIOMOL (Plymouth Meeting, PA). Fura-2AM
was obtained from Dojin Laboratories (Kumamoto,
Japan).
ANALYSIS OF RESULTS
All data are expressed as means ± standard deviation
(SD). The response to an agent is described as a per-
centage of the maximal response. Parameters were
compared using Student’s t-test and ANOVA, fol-
lowed by the Bonferroni post hoc test. A probability
below 0.05 (P < 0.05) was considered to be a signifi-
cant difference.
RESULTS
EFFECT OF PRE-TREATMENT WITH S1P ON
THE SUBSEQUENT RESPONSE TO β-ADRE-
NOCEPTOR AGONISTS
Application of 0.3 μM ISO to airway smooth muscle
caused a marked inhibition of 1 μM MCh-induced
contraction, which was markedly attenuated by pre-
exposure of the tissues to S1P (0.1 μM) for 60 min.
SIP exposure alone did not augment MCh-induced
contraction (Fig. 1A). The values of percent contrac-
tion for MCh with ISO inhibition after exposure to
the normal bathing solution (control) and to 0.1 μM
S1P for 60 min were 24.8 ± 4.4 (n = 10) and 98.3 ±
5.3% (n = 10), respectively (p < 0.05). After exposure
to S1P (0.001 - 0.1 μM), the inhibitory effects of ISO
were attenuated in a concentration-dependent man-
ner (Fig. 1B). Moreover, following exposure to 0.1
μM S1P for 15 - 60 min, the subsequent response to
ISO was markedly attenuated in a time-dependent
manner. The values of percent contraction after expo-
sure to 0.1 μM S1P for 15 and 30 min were 82.0 ± 5.7
(n = 10, P < 0.05) and 94.6 ± 5.3% (n = 10, P < 0.05), re-
spectively (Fig. 1C).
EFFECT OF PRE-TREATMENT WITH S1P ON
THE SUBSEQUENT RESPONSE TO cAMP RE-
LATED AGENTS THAT BYPASS β-ADRENO-
CEPTORS
After the tissues were exposed to 0.001 μM S1P for
60 min, the inhibitory effects of 10 μM forskolin on 1
μM MCh-induced contraction were not significantly
attenuated (Fig. 2A). The values of percent contrac-
tion for MCh with forskolin after exposure to the nor-
mal bathing solution and to 0.001 μM S1P for 60 min
were 19.6 ± 12.6 (n = 8) and 23.3 ± 9.4% (n = 8), re-
spectively (not significant, Fig. 2B). However, after
exposure to 0.1 μM S1P for 60 min, the inhibitory ef-
fects of forskolin were markedly attenuated (Fig. 2A,
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Fig.　1　β-Adrenergic action after exposure to S1P. A: A typical example of the in-
hibitory effect of 0.3 μM isoprenaline (ISO) on 1 μM methacholine (MCh)-induced 
contraction before and after exposure to 0.1 μM S1P for 60 min. B: The values of 
percent contraction for MCh with ISO after exposure to the normal bathing solution 
(control, open columns) and to S1P (0.001-0.1 μM, closed columns) for an equiva-
lent number of min. C: The values of percent contraction for MCh with ISO after 
exposure to the normal bathing solution (control, open columns) and to 0.1 μM 
S1P (closed columns) for 15, 30, and 60 min, respectively.  *P < 0.05.
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B). Under this experimental condition, the values of
percent contraction for MCh with forskolin were in-
creased to 58.2 ± 11.1% (n = 10, P < 0.01). After expo-
sure to S1P (0.001 - 0.1 μM), the inhibitory effects of
forskolin were attenuated in a concentration-
dependent manner (Fig. 2B). Moreover, the subse-
quent response to forskolin was markedly attenuated
in a time-dependent manner (Fig. 2C). The values of
percent contraction after exposure to 0.1 μM S1P for
15, 30 and 60 min were 42.8 ± 7.8 (n = 10, P < 0.05),
53.2 ± 8.8 (n = 10, P < 0.05) and 58.2 ± 11.1% (n = 10, p
< 0.05), respectively (Fig. 2C).
INVOLVEMENT OF RHO-KINASE IN THE RE-
DUCED RESPONSIVENESS TO FORSKOLIN IN-
DUCED BY S1P
After the tissues were exposed to 0.1 μM S1P in the
presence of 0.001 μM Y-27632 for 60 min, the inhibi-
tory effects of 10 μM forskolin on 1 μM MCh-induced
contraction were significantly attenuated (Fig. 3A).
However, after exposure to 0.1 μM S1P together with
1 μM Y-27632 for an equivalent time, the inhibitory ef-
fects of forskolin were not attenuated (Fig. 3A). Y-
27632 (0.001 - 1 μM) inhibited the reduced respon-
siveness to forskolin induced by S1P in a
concentration-dependent manner (Fig. 3B). The val-
ues of percent contraction for MCh with forskolin af-
ter exposure to 0.1 μM S1P in the presence of 0.01
Effects of S1P on β-adrenergic Action
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Fig.　2　Response to cAMP-related agents after exposure to S1P. A: A typical ex-
ample of the inhibitory effect of 10 μM forskolin on 1 μM MCh-induced contraction 
before and after exposure to 0.001 (upper trace) and 0.1 μM S1P (lower trace) for 
60 min. B: The values of percent contraction for MCh with forskolin after exposure 
to the normal bathing solution (control, open column) and to S1P (0.001-0.1 μM, 
closed columns) for an equivalent number of min. C: The values of percent con-
traction for MCh with forskolin after exposure to the normal bathing solution (con-
trol, open column) and to 0.1 μM S1P (closed columns) for 15, 30, and 60 min, re-
spectively.  *P < 0.05, **P < 0.01.
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and 1 μM Y-27632 were 46.4 ± 10.2 (n = 10, P < 0.05)
and 28.9 ± 13.4% (n = 10, P < 0.05), respectively (Fig.
3B).
INVOLVEMENT OF Ca2+ SENSITIZATION IN THE
REDUCED RESPONSIVENESS TO FORSKOLIN
INDUCED BY S1P
When S1P was applied to fura-2 loaded strips, force
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Fig.　3　The effect of Rho-kinase on S1P-induced β-adrenergic desensitization. A: 
A typical example of the inhibitory effect of forskolin on MCh-induced contraction 
before and after exposure to 0.1 μM S1P in the presence of 0.001 (upper trace) 
and 1 μM Y-27632 (lower trace) for 60 min. B: The values of percent contraction 
for MCh with forskolin after exposure to an equi-molar amount of S1P in the ab-
sence (control, open column) and presence of Y-27632 (0.001-1 μM, closed col-
umns) .  *P < 0.05, **P < 0.01.
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was generated with an increase in [Ca2+]i. The values
of percent contraction and percent F340F380 for 0.1
μM S1P were 8.6 ± 7.9 and 18.1 ± 13.6% (n = 8), re-
spectively (Fig. 4A). The effect of S1P on both ten-
sion and [Ca2+]i had disappeared within 5 min after
washing out (Fig. 4A). After exposure to 0.1 μM S1P
for 15 min, the inhibitory effect of 10 μM forskolin on
1 μM MCh-induced contraction was markedly attenu-
ated, whereas the inhibitory effect of forkolin on
MCh-induced [Ca2+]i was not affected (Fig. 4A). The
values of percent contraction for MCh with forskolin
after exposure to the normal bathing solution and to
0.1 μM S1P for 15 min were 12.1 ± 7.7 (n = 8) and
63.1 ± 9.6% (n = 8), respectively (p < 0.01, Fig. 4A).
The values for percent F340F380 were 36.4 ± 9.3 (n =
8) and 41.6 ± 11.3% (n = 8), respectively (not signifi-
cant, Fig. 4B).
INVOLVEMENT OF Ca2+ SIGNALING BY S1P IN
THE SUBSEQUENT RESPONSE TO FORSKOLIN
When Y-27632 (0.0001-0.1 μM) was cumulatively ap-
plied, 0.1 μM S1P-induced contraction was inhibited
in a concentration-dependent manner, whereas the
SIP-induced [Ca2+]i increase was not affected (data
not shown). The values of percent contraction and
percent F340F380 for 0.1 μM S1P with 0.1 μM Y-27632
were 0.0 ± 0.0 (p < 0.01, n = 8) and 16.1 ± 7.8% (not
significant, n = 8), respectively (Fig. 5A). After incu-
bation with 0.1 μM S1P in the presence of 0.1 μM Y-
27632 for 15 min, the reduced responsiveness to
forskolin induced by pre-exposure to S1P returned to
the control level without a reduction in [Ca2+]i. The
Effects of S1P on β-adrenergic Action
Allergology International Vol 61, No2, 2012 www.jsaweb.jp 317
Fig.　4　The effect of Ca2+ sensitization on S1P-induced β-adrenergic desensitiza-
tion. A: A typical example of a simultaneous record of tension (upper trace) and 
F340/F380 (lower trace) in the inhibitory effects of forskolin on MCh-induced contrac-
tion before and after exposure to 0.1 μM S1P for 15 min. B: The values of percent 
contraction and F340/F380 for MCh with forskolin before and after exposure to the 
normal bathing solution (control, open columns) and to 0.1 μM S1P (closed col-
umns) for 15 min.  **P < 0.01.
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value of percent contraction and percent F340F380
were 26.1 ± 5.4 (P < 0.01, n = 8) and 38.6 ± 18.2% (not
significant, n = 8), respectively (Fig. 5B). In contrast,
SKF-96365 inhibited S1P-induced contraction with re-
ducing [Ca2+]i in a concentration-dependent manner
(data not shown). SKF-96365 (0.1 μM) completely in-
hibit both the tension and the increased [Ca2+]i in-
duced by 0.1 μM S1P (Fig. 5A), however, after expo-
sure to S1P in the presence of SKF-96365, the re-
duced responsiveness to forskolin induced by S1P
was not reversed. The values of percent contraction
and percent F340F380 were 61.4 ± 22.7 (not signifi-
cant) and 40.9 ± 20.9% (not significant, n = 8), respec-
tively (Fig. 5B).
INVOLVEMENT OF Gi IN THE INDUCTION OF
S1P-INDUCED β-ADRENERGIC DESENSITIZA-
TION
Pre-treatment of the fura-2-unloaded tissues with 1
μgml PTX for 6 h caused inhibition of the reduced
responsiveness to forskolin induced by S1P. Values
of percent contraction for MCh with forskolin after
exposure to 0.1 μM S1P for 60 min followed by treat-
ment without and with 1 μgml PTX for 6 h, were
66.9 ± 12.8 (n = 8) and 25.5 ± 8.0% (n = 8, P < 0.01), re-
spectively (Fig. 6A, B). Pre-treatment of the tissues
with PTX (0.001 - 1 μgml) inhibited the reduced re-
sponsiveness to forskolin induced by S1P in a
concentration-dependent manner (Fig. 6B).
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Fig.　5　The effect of S1P-induced Ca2+ sensitization on β-adrenergic de-
sensitization. A: Values of percent contraction (open columns) and F340/F380 
(closed columns) in response to S1P, S1P with Y-27632, and S1P with 
SKF-96365. B: Values of percent contraction (open columns) and F340/F380 
(closed columns) for MCh with forskolin after exposure to S1P, S1P with 
Y-27632, and S1P with SKF-96365 for 15 min.  **P < 0.01.
100
80
60
40
20
0
%
R
es
po
ns
e
S1P S1P
Y-27632
S1P
SKF-96365
**
**
**
A
B
100
80
60
40
20
0
%
 R
es
po
ns
e
S1P S1P
Y-27632
S1P
SKF-96365
**
THE EFFECTS OF S1P, PTX AND Y-27632 ON
THE INTRACELLULAR LEVEL OF cAMP IN-
DUCED BY FORSKOLIN
Application of 10 μM forskolin caused an increase in
the intracellular level of cAMP from 4.2 ± 3.1 to 358.2
± 168.4 pmolmg protein in tracheal smooth muscle
(Fig. 7). However, when the tissues were exposed to
0.1 μM S1P for 60 min, the intracellular level of cAMP
induced by 10 μM forskolin was markedly reduced to
116.2 ± 66.8 pmolmg protein (n = 8, P < 0.05). When
the tissues were treated with 0.1 μgml PTX for 6 h
before exposure to S1P, a reduction in the intracellu-
lar level of cAMP by S1P returned to the control
level. The value of the cAMP level induced by
forskolin was significantly increased to 304.8 ± 116.4
pmolmg protein (n = 10, P < 0.05). Moreover, when
the tissues were exposed to 0.1 μM S1P with 1 μM Y-
27632 for 60 min, a reduction in the intracellular level
of cAMP by S1P was also reversed. The value of the
cAMP level induced by forskolin was significantly in-
creased to 392.4 ± 190.6 pmolmg protein (n = 10, P <
0.05).
DISCUSSION
The major findings of the present study are summa-
rized as follows: 1) External application of S1P causes
the heterologus desensitization of β-adrenoceptors in
airway smooth muscle. 2) Y-27632-sensitive Ca2+ sen-
sitization is involved in this reduced responsiveness
to β-agonists induced by pre-exposure to S1P. 3) Gi
processes are essential for the Ca2+ sensitization in-
duced by pre-exposure to S1P.
As shown in Figure 1, 2, pre-exposure to S1P im-
pairs the function of β-adrenoceptorsAC processes.
After exposure to S1P (<0.01 μM), response to ISO
was markedly attenuated, on the other hand, re-
sponse to forskolin was not attenuated, indicating
that S1P impairs β-adrenoceptors, but AC is still ac-
tive under this experimental condition. Therefore, at
less than 0.01 μM of S1P, pre-exposure to S1P causes
β-adrenergic desensitization independent of PKA ac-
tivity. To determine whether cAMPPKA processes
are involved in this phenomenon, the tissues were ex-
posed to S1P in the presence of 300 μM Rp-cAMP, a
membrane-permeable PKA inhibitor. Reduced re-
sponsiveness to ISO was not significantly inhibited
(data not shown), similar to a previous report shown
that reduced responsiveness to ISO after excessive
exposure to ISO is not influenced in the presence of
Rp-cAMP.27 There are two pathways in β-adrenergic
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Fig.　6　The effect of PTX on β-adrenergic desensitization by S1P. A: Relaxant ef-
fects of 10 μM forskolin on 1 μM MCh-induced contraction after exposure to 0.1 
μM S1P for 1 h subsequent to treatment with the normal bathing solution (sham in-
cubation, upper trace) and 1 μg/ml PTX (lower trace) for 6 h. B: The values of per-
cent contraction for MCh with forskolin after exposure to an equi-molar amount of 
S1P for 1 h subsequent to treatment with the normal bathing solution (control, 
open column) and PTX (0.001-1 μg/ml, closed columns) for 6 h.  *P < 0.05, **P < 
0.01.
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action on airway smooth muscle, i.e. 1) cAMP-
dependent protein kinase processes (the classical
pathway), 2) cAMP-independent processes (probably
G protein direct action).28-30 Under this experimental
condition of pre-exposure to S1P (<0.01 μM), cAMP-
independent, G protein direct processes described
above may be impaired.
The ability of pre-exposure to S1P to reduce the re-
sponse to β-adrenoceptor agonists is mediated by het-
erologous desensitization because not only a β-
adrenoceptor agonist but also a cAMP-related agent
was affected. This observation is consistent with the
reduced responsiveness to β-agonists after exposure
to TGF-β1 and PDGF, growth factors23,31 and IL-1β, a
proinflammatory cytokine.32 On the other hand, pre-
exposure to lysophosphatidylcholine (Lyso-PC), an-
other lysophospholipid synthesized by phospholipase
A2 (PLA2),22 and tryptase, a trypsin-like neural serine-
class protease that is released from mast cells,33
cause β-adrenergic desensitization mediated by ho-
mologous processes, which differs from pre-exposure
to S1P. Little is currently known about the clinical
relevance for difference between homologous and
heterologous desensitizastion of β-adrenoceptors.
Subsensitivity to forskolin mediated by pre-
exposure to S1P was significantly inhibited in the
presence of 0.01 μM Y-27632 (Fig. 3B), similar to the
inhibition induced by pre-exposure to Lyso-PC22 and
tryptase.33 The inhibition constant (Ki) value of Y-
27632 for inhibition of Rho-kinase is generally consid-
ered to be 0.14 μM in vitro.34 These results suggest
that Rho-kinase is related to β-adrenergic desensitiza-
Makino Y et al.
320 Allergology International Vol 61, No2, 2012 www.jsaweb.jp
Fig.　7　The effects of S1P, PTX and Y-27632 on cAMP accumulation in-
duced by forskolin. Values of the intracellular concentrations of cAMP in 
strips exposed to 10 μM forskolin in the absence and presence of 0.1 μM 
S1P for 60 min, and the values in strips exposed to an equi-molar concen-
tration of forskolin and S1P in the presence of 1 μg/ml PTX for 6 h and 1 
μM Y-27632 for 60 min.  *P < 0.05.
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tion by pre-treatment with S1P. On the other hand,
S1P (0.3 - 3 μM) causes an increase in activity of
MYPT1 in a concentration-dependent manner.4 0.1
μM S1P caused a significant, but modest activation of
MYPT1 in human airway smooth muscle (data not
shown), similar to 0.3 μM S1P. Although 0.1 μM S1P
may activate Rho-kinase in guinea pig tracheal
smooth muscle, its action may not be so meaningful
for the physiological response. Rho-kinase mediated
pathways independent of MYPT-1 may be involved in
this phenomenon.
Ca2+ sensitization is involved in β-adrenergic de-
sensitization induced by pre-exposure to S1P (Fig.
4A, B), similar to that induced by pre-exposure to
Lyso-PC22 and tryptase.33 Y-27632 inhibited S1P-
induced contraction with no change in [Ca2+]i, and
the reduced responsiveness to forskolin was reversed
to the control level with no change in [Ca2+]i after ex-
posure to S1P in the presence of Y-27632 (Fig. 5A, B).
This result indicates that S1P-induced Ca2+ sensitiza-
tion leads to the β-adrenergic desensitization medi-
ated by Rho-kinase. β-Adrenoceptor agonists and
cAMP-related agents inhibit MCh-induced contrac-
tion with a decrease in [Ca2+]i (Ca2+ dynamics).35
However, inactivation of not only Ca2+ dynamics but
also Ca2+ sensitization results in relaxation of airway
smooth muscle when β-adrenoceptor agonists and
other cAMP-related agents were applied.36 On the
other hand, to determine involvement of Rac, other
Rho family, the tissues were incubated with S1P in
the presence of NSC23766, an inhibitor of Rac, and
PD98059, an inhibitor of mitogen-activated protein
kinase kinase. The reduced responsiveness to
forskolin induced by pre-exposure to S1P was not at-
tenuated under these experimental conditions (data
not shown). Ca2+ sensitization is also mediated by
protein kinase CCPI-17 processes. To determine in-
volvement of protein kinase C, the tissues were incu-
bated with bisindolylmaleimide, an inhibitor of pro-
tein kinase C. The effects of pre-exposure to S1P
were not inhibited (data not shown). Mechanisms
other than Rho-kinase may not be responsible for this
phenomenon
S1P also causes contraction in airway smooth mus-
cle that is accompanied by an increase in [Ca2+]i via
Ca2+ influx passing through Ca2+ channels nonselec-
tively.4 Although SKF-96365, a nonselective inhibitor
of Ca2+ channels, suppressed S1P-induced contrac-
tion and reduced [Ca2+]i, pre-treatment with S1P in
the presence of SKF-96365 did not reverse the re-
duced responsiveness to forskolin induced by S1P
(Fig. 5B). This observation is consistent with β-
adrenergic desensitization induced by pre-exposure
to tryptase as shown previously.33 S1P-induced Ca2+
dynamics does not lead to the heterologous desensiti-
zation of β-aderenoceptors.
We sought to determine the involvement of post re-
ceptor signal transduction pathways in the S1P-
induced β-adrenergic desensitization via Ca2+ sensiti-
zation. As shown in Figure 6, the loss of effects of
forskolin induced by S1P was significantly inhibited
after exposure to 1 μgml PTX. Since exposure to
PTX causes a functional uncoupling of Gi from its as-
sociated receptor via its ADP ribosylation, Gi may me-
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diate the S1P-induced heterologous desensitization of
β-adrenoceptors. Pre-exposure to S1P (>0.1 μM) en-
hances MCh-induced contraction mediated by an
augmentation in sensitivity to intracellular Ca2+ via
GiRhoARho-kinase processes.4 Under this experi-
mental condition of S1P (>0.1 μM), the inhibitory ef-
fects of ISO on MCh (β-adrenergic action) are not
able to evaluate accurately. In this study, β-
adrenergic action was examined after exposure to
S1P (0.1 μM). Consequently, ISO- and forskolin-
induced action was markedly attenuated mediated by
the same processes. Hence, S1PGi linkage causes
Ca2+ sensitization mediated by activation of Rho-
kinase, leading to hypersensitivity to MCh (airway
hyperresponsiveness), and subsensitivity to β-
adrennoceptor agonists (β-adrenergic desensitiza-
tion) in airway smooth muscle.
The role of concentrations of intracellular cAMP in
this pre-exposure to S1P mediated β-adrenergic de-
sensitization was examined as shown in Figure 7. S1P
reduced the concentrations of intracellular cAMP that
were increased by forskolin, indicating that β-
adrenoceptor phosphorylation via PKA activation is
unrelated to this phenomenon. Incubation with S1P
in the presence of PTX and Y-27632 reversed the con-
centrations of intracellular cAMP that were reduced
by S1P to the control level (Fig. 7), also indicating
that phosphorylation induced by cAMPPKA proc-
esses is unrelated to this phenomenon. In this study,
the concentrations of intracellular cAMP are conse-
quent to the activity of Gi, and are not related to the
induction of β-adrenoceptor desensitization. Previous
reports have demonstrated that cAMPPKA inhibits
the activation of RhoA,37,38 and that Gi activates
RhoA.4 This present study demonstrates that the Gi
RhoARho-kinase process plays a fundamental role
for this pre-exposure to S1P-induced β2-adrenergic
desensitization. However, this signal transduction
pathway has never demonstrated in molecular bio-
logical technique.39 Further studies for this pathway
may contribute to developing a novel strategy of
therapeutics in bronchial asthma.
Since cytosolic PLA2 (cPLA2) and cyclooxygenase-
2 (COX-2) are activated by S1P,40 prostaglandins are
synthesized in the cytosolic side of airway smooth
muscle cells. Pre-exposure to S1P may cause β-
adrenergic desensitization mediated by increasing
concentrations of endogenous prostaglandins. How-
ever, in this study, indomethacin, a nonselective in-
hibitor of COX, was applied throughout these experi-
ments to abolish the spontaneous mechanical tone.
Hence, an augmentation in COX-2 activity may not be
related to the pre-exposure to S1P-induced β-
adrenergic desensitization. On the other hand, pre-
exposure to Lyso-PC, which is synthesized from PLA2
in the cell membrane, causes β-adrenergic desensiti-
zation via Ca2+ sensitization induced by Rho-kinase in
airway smooth muscle22 as same as the observations
shown in this study using pre-exposure to S1P. Acti-
vation of PLA2 may be involved in this β-adrenergic
desensitization induced by S1P.
In conclusion, although the clinical relevance of
our observation remains unknown, these results may
provide evidence that S1P, which is released from
mast cells, brings about not only the principal patho-
physiology of bronchial asthma (airway obstruction,
airway hyperresponsiveness, pro-inflammatory cy-
tokine production, eosinophil recruitment and edema
in the airway walls) but also dysfunction of β-
adrenoceptors in patients with this disease. Ca2+ sen-
sitization regulated by the GiRho-kinase pathway
may be a therapeutic target for this disease.
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